← Back to headlines
Incannex begins Phase 2 clinical trial for IHL-42X therapy
The biotech firm announced the dosing of the first patient in its DReAMzz study, marking a key milestone in the development of the investigational treatment.
25 Aug, 12:46 — 25 Aug, 12:46
Sources
Showing 1 of 1 sources
Related Stories
Busy Philipps Reveals She Underwent Surgery to Remove Rare Brain Tumor
36m ago
Closing Arguments Set as Murder Trial of Chris Benoit Nears Conclusion
41m ago
Eight-Year-Old Boy Dies After Electric Shock From Water Cooler in UAE
45m ago
FDA Grants Expedited Approval to Landmark Pancreatic Cancer Drug
56m ago